Detected ·
Qureight
$20M—
Qureight, a Cambridge-based AI imaging company focused on lung and heart disease clinical trials, has secured $20M in Series B funding, with participation from existing investors including Hargreave Hale AIM VCT. The funding will support the continued development of Qureight's AI-powered imaging platform, helping pharma companies accelerate treatment development through advanced imaging and deep learning biomarkers.
- Website
- www.qureight.com
- linkedin.com/company/qureight
- Amount
- $20 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-06 20:03:31 UTC
- Signal ID
- 079acc2a-74b0-4b8f-8baf-64ed945ef888
As the API returns it
{
"id": "079acc2a-74b0-4b8f-8baf-64ed945ef888",
"created_at": "2026-08-06T20:03:31.930262Z",
"company_name": "Qureight",
"company_website_url": "www.qureight.com",
"company_linkedin_url": "https://www.linkedin.com/company/qureight",
"event_type": "funding",
"funding_amount": 20000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Qureight, a Cambridge-based AI imaging company focused on lung and heart disease clinical trials, has secured $20M in Series B funding, with participation from existing investors including Hargreave Hale AIM VCT. The funding will support the continued development of Qureight's AI-powered imaging platform, helping pharma companies accelerate treatment development through advanced imaging and deep learning biomarkers.*"
}